Government of Ukraine Report issue

Government Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2015
NCT02596243
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Kyiv City Clinical Endocrinology Center | Lviv State Laboratory Center, Ministry of Health of Ukraine | Oleg Levada | State Institution, Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine | Ukrainian Institute on Public Health Policy | Ukrainian Research and Practical Centre of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma in Situ (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 2)

Cognitive Dysfunction (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 10